Biogerontology

Daily patterns of serotonin and body clock genes in the brain's time-keeping center in a Parkinson’s rat model and how melatonin may affect them

Updated

Abstract

Significant decreases in serotonin-related compounds were observed, with reductions of approximately 96% in melatonin levels in a rat model of Parkinson's disease.

  • The mean 24 h levels of tryptophan, 5-hydroxytryptophan, serotonin, N-acetyl serotonin, and melatonin decreased by approximately 63%, 51%, 76%, 96%, and 96%, respectively.
  • Increased levels of 5-methoxy indole acetic acid, 5-methoxy tryptophol, and 5-hydroxy tryptophol suggest heightened serotonin breakdown in the Parkinson's disease model.
  • The rhythmic expression of clock genes rPer1, rCry1, and rBmal1 was significantly reduced, while rPer2 levels increased by about 1.7-fold.
  • Melatonin administration restored the daily rhythm phase of rPer1 in the model, indicating varying sensitivity of clock components to melatonin.
  • Neuroprotective effects were observed during the dark phase in animals treated with both rotenone and melatonin.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free